KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $129.0 million.

  • Bio-Rad Laboratories' Accounts Payables rose 547.83% to $129.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $129.0 million, marking a year-over-year increase of 547.83%. This contributed to the annual value of $129.0 million for FY2025, which is 547.83% up from last year.
  • Bio-Rad Laboratories' Accounts Payables amounted to $129.0 million in Q4 2025, which was up 547.83% from $128.8 million recorded in Q3 2025.
  • Over the past 5 years, Bio-Rad Laboratories' Accounts Payables peaked at $161.0 million during Q1 2023, and registered a low of $102.8 million during Q1 2024.
  • Moreover, its 5-year median value for Accounts Payables was $137.1 million (2021), whereas its average is $136.1 million.
  • Its Accounts Payables has fluctuated over the past 5 years, first tumbled by 3617.18% in 2024, then soared by 3420.92% in 2025.
  • Quarter analysis of 5 years shows Bio-Rad Laboratories' Accounts Payables stood at $141.9 million in 2021, then dropped by 4.86% to $135.0 million in 2022, then increased by 7.08% to $144.6 million in 2023, then fell by 15.42% to $122.3 million in 2024, then rose by 5.48% to $129.0 million in 2025.
  • Its Accounts Payables was $129.0 million in Q4 2025, compared to $128.8 million in Q3 2025 and $139.3 million in Q2 2025.